Under the auspices of the PRECINCT Canine Trials Network the (human) IL-15 superagonist AnktivaR is being tested in combination with inhaled (human) IL-15 in dogs with melanoma or osteosarcoma driven lung metastases [PIs: Canter RJ, Rebhun RB. Here, IL15 is linked to melanoma.